ES2145023T3 - Gel anti-inflamatorio y analgesico de diclofenac. - Google Patents

Gel anti-inflamatorio y analgesico de diclofenac.

Info

Publication number
ES2145023T3
ES2145023T3 ES93119125T ES93119125T ES2145023T3 ES 2145023 T3 ES2145023 T3 ES 2145023T3 ES 93119125 T ES93119125 T ES 93119125T ES 93119125 T ES93119125 T ES 93119125T ES 2145023 T3 ES2145023 T3 ES 2145023T3
Authority
ES
Spain
Prior art keywords
diclofenac
cellulose
molecular weight
weight
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93119125T
Other languages
English (en)
Inventor
Yasuo Ikeda
Shuichi Kasai
Satoru Enomoto
Katsumi Imamori
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2145023T3 publication Critical patent/ES2145023T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA PREPARACION DE GEL ANALGESICO Y ANTIINFLAMATORIO QUE CONTIENE DICLOFENAC O SUS SALES, UN ESTER DE ACIDO DIBASICO, UN ALCOHOL INFERIOR, Y UN POLIMERO NO IONICO O UNA MEZCLA DE POLIMEROS NO IONICOS SELECCIONADOS DEL GRUPO COMPUESTO DE (A) 1,5-4% DE PESO DE HIDROXIPROPILO DE CELULOSA QUE TIENE UN PESO MOLECULAR DE 500.000 O MAYOR. (B) 2-4% DE PESO DE HIDROXIETILO DE CELULOSA QUE TIENE UN PESO MOLECULAR DE 1.250.000 O MAYOR, Y (C) 1,5-4% DE PESO DE UNA MEZCLA DE HIDROXIPROPILO DE CELULOSA QUE TIENE UN PESO MOLECULAR DE 500.000 O MAYOR E HIDROXIFENILO DE CELULOSA QUE TIENE UN PESO MOLECULAR DE 1.250.000 O MAYOR, Y QUE TIENE UNA VISCOSIDAD DE 5.000-35.000 CPS Y UN VALOR DE RENDIMIENTO DE 5 DYN CM (AL CUADRADO) O MAYOR. LA PREPARACION DE GEL ES EXCELENTE EN LA ABSORCION PERCUTANEA DE DICLOFENAC O SUS SALES Y PRODUCE BUENAS PROPIEDADES DE USO Y EFECTOS MEDICOS SUPERIORES AL DICLOFENAC O SUS SALES.
ES93119125T 1992-12-04 1993-11-26 Gel anti-inflamatorio y analgesico de diclofenac. Expired - Lifetime ES2145023T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4325632A JP2523428B2 (ja) 1992-12-04 1992-12-04 消炎鎮痛ゲル製剤

Publications (1)

Publication Number Publication Date
ES2145023T3 true ES2145023T3 (es) 2000-07-01

Family

ID=18179022

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93119125T Expired - Lifetime ES2145023T3 (es) 1992-12-04 1993-11-26 Gel anti-inflamatorio y analgesico de diclofenac.

Country Status (10)

Country Link
US (1) US5422102A (es)
EP (1) EP0600395B1 (es)
JP (1) JP2523428B2 (es)
KR (1) KR100245994B1 (es)
CA (1) CA2110119C (es)
DE (1) DE69328067T2 (es)
ES (1) ES2145023T3 (es)
HK (1) HK1012570A1 (es)
SG (1) SG47083A1 (es)
WO (1) WO1994013281A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
US6673808B1 (en) * 1998-04-27 2004-01-06 Fujisawa Pharmaceutical Co., Ltd. Medicinal compositions
WO1999055660A1 (en) * 1998-04-28 1999-11-04 Russinsky Limited Process for the preparation of aceclofenac
KR100348100B1 (ko) * 1998-07-31 2002-11-07 하나제약 주식회사 2-[(2,6-디클로로페닐)아미노]페닐아세톡시아세트산의제조방법
US20030198616A1 (en) * 2002-04-23 2003-10-23 Combe Incorporated Moisturizing skin gel and method
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
WO2005027977A2 (en) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders
JP4820065B2 (ja) * 2004-05-24 2011-11-24 同仁医薬化工株式会社 消炎鎮痛外用水性液剤
JP5432716B2 (ja) 2006-10-17 2014-03-05 ヌーボ リサーチ インコーポレイテッド ジクロフェナクゲル
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8697043B1 (en) * 2013-01-08 2014-04-15 Chattem, Inc. Odor suppression of volatile organic analgesic compounds and method of use
JP6676548B2 (ja) 2015-01-30 2020-04-08 株式会社 メドレックス 水性外用剤
CN112516081B (zh) * 2020-12-16 2023-03-10 郑州百瑞动物药业有限公司 一种双氯芬酸注射液及其制备方法
WO2022249748A1 (ja) * 2021-05-24 2022-12-01 住友精化株式会社 ゲル状組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
JPS63222121A (ja) * 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性ゲル製剤
JPH0696527B2 (ja) * 1987-05-20 1994-11-30 佐藤製薬株式会社 消炎鎮痛ゲル剤
DK0450123T3 (da) * 1990-04-05 1995-08-21 Knoll Ag Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
CA2058975C (en) * 1990-10-30 2000-06-06 Shuichi Kasai Antiinflammatory gel preparation
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤

Also Published As

Publication number Publication date
US5422102A (en) 1995-06-06
DE69328067T2 (de) 2000-09-14
JPH07173058A (ja) 1995-07-11
EP0600395A1 (en) 1994-06-08
KR940013497A (ko) 1994-07-15
KR100245994B1 (ko) 2000-04-01
CA2110119C (en) 2003-05-27
SG47083A1 (en) 1998-03-20
JP2523428B2 (ja) 1996-08-07
WO1994013281A1 (en) 1994-06-23
CA2110119A1 (en) 1994-06-05
EP0600395B1 (en) 2000-03-15
HK1012570A1 (en) 1999-08-06
DE69328067D1 (de) 2000-04-20

Similar Documents

Publication Publication Date Title
ES2145023T3 (es) Gel anti-inflamatorio y analgesico de diclofenac.
ATE14192T1 (de) Arzneimittel.
US3868447A (en) Hema paste
ES2192256T3 (es) Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
KR890700344A (ko) 약학 제제
FI916187A0 (fi) Piidioksidia sisältävä tuote ja menetelmä sen valmistamiseksi
GB1279294A (en) Surgical and skin dressings and excipients for use in forming them
DE59209907D1 (de) Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
ES2155604T3 (es) Mezclas de polimeros que contienen acrilato.
KR910011243A (ko) 서방성 약제 용량 단위
KR860003006A (ko) 의약용 경질 캡슐 및 그의 제조방법
ATE110956T1 (de) Auf die mundschleimhaut aufbringbarer film und arzneizubereitung auf der basis dieses films.
DE59308257D1 (de) 25-carbonsäure-derivate in der vitamin d-reihe, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
EA199700201A1 (ru) Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот
ATE103893T1 (de) 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung; diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel.
YU46903B (sh) Postupak za dobijanje polimernog vlakna, koje sadrži lek, za zadržavanje u gastrointestinalnom traktu
WO1997028794A1 (fr) Solution aqueuse transparente de diclofenac sodique, compositions medicinales, et utilisations
ES2032323T3 (es) Un procedimiento para la produccion de una preparacion antifungica formadora de pelicula.
FI935051A (fi) Lanolinderivat som penetrationfraemjande aemnen och anvaendning av dessa i preparat innehaollande laekemedel eller andra biologiskt aktiva substanser
US3922341A (en) Aerosol hair sprays containing ethyl or butyl monoester of copolymer of vinyl monomer and maleic acid
ES2143833T3 (es) Acidos y esteres de la diosmetina y composiciones farmaceuticas que los contienen.
ES2082345T3 (es) Composicion del tipo de barra con cloruro de sodio y alcohol estearilico.
ATE64307T1 (de) Injizierbare arzneiformulierungen von substanzen mit allgemeiner anaesthetischer wirkung.
JPS6363614A (ja) イソチペンジル類含有組成物
ONTENTS reter al C-,..

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 600395

Country of ref document: ES